These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25280813)

  • 41. Effects of hypoxia inducible factor-1α on apoptotic inhibition and glucocorticoid receptor downregulation by dexamethasone in AtT-20 cells.
    Zhang C; Qiang Q; Jiang Y; Hu L; Ding X; Lu Y; Hu G
    BMC Endocr Disord; 2015 May; 15():24. PubMed ID: 26002039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of Cushing disease.
    Riebold M; Kozany C; Freiburger L; Sattler M; Buchfelder M; Hausch F; Stalla GK; Paez-Pereda M
    Nat Med; 2015 Mar; 21(3):276-80. PubMed ID: 25665180
    [TBL] [Abstract][Full Text] [Related]  

  • 43. β-arrestin expression in corticotroph tumor cells is modulated by glucocorticoids.
    Gatto F; Feelders RA; van der Pas R; van Koetsveld P; Bruzzone E; Arvigo M; Dogan F; Lamberts S; Ferone D; Hofland L
    J Endocrinol; 2020 Apr; 245(1):101-113. PubMed ID: 32027601
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of Heat Shock Factor 1 Enhances Repressive Molecular Mechanisms on the POMC Promoter.
    Ciato D; Li R; Monteserin Garcia JL; Papst L; D'Annunzio S; Hristov M; Tichomirowa MA; Belaya Z; Rozhinskaya L; Buchfelder M; Theodoropoulou M; Paez-Pereda M; Stalla GK
    Neuroendocrinology; 2019; 109(4):362-373. PubMed ID: 30995664
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hormonal aggressiveness according to the expression of cellular markers in corticotroph adenomas.
    Lim JS; Lee MK; Choi E; Hong N; Il Jee S; Kim SH; Lee EJ
    Endocrine; 2019 Apr; 64(1):147-156. PubMed ID: 30474823
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decreased expression of SFRP2 promotes development of the pituitary corticotroph adenoma by upregulating Wnt signaling.
    Ren J; Jian F; Jiang H; Sun Y; Pan S; Gu C; Chen X; Wang W; Ning G; Bian L; Sun Q
    Int J Oncol; 2018 Jun; 52(6):1934-1946. PubMed ID: 29620167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aberrant Nuclear Translocation of E2F1 and Its Association in Cushing's Disease.
    Araki T; Wang J; Lawrence R; Kawakami Y
    Endocrinology; 2022 Aug; 163(8):. PubMed ID: 35678423
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Different levels of various glucocorticoid-regulated genes in corticotroph adenomas.
    Evang JA; Bollerslev J; Casar-Borota O; Lekva T; Ramm-Pettersen J; Berg JP
    Endocrine; 2013 Aug; 44(1):220-7. PubMed ID: 23315031
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of RXR Agonists on Cell Proliferation/Apoptosis and ACTH Secretion/Pomc Expression.
    Saito-Hakoda A; Uruno A; Yokoyama A; Shimizu K; Parvin R; Kudo M; Saito-Ito T; Sato I; Kogure N; Suzuki D; Shimada H; Yoshikawa T; Fujiwara I; Kagechika H; Iwasaki Y; Kure S; Ito S; Sugawara A
    PLoS One; 2015; 10(12):e0141960. PubMed ID: 26714014
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nur77 gene expression levels were involved in different ACTH-secretion autonomy between Cushing's disease and subclinical Cushing's disease.
    Tabuchi Y; Kitamura T; Fukuhara A; Mukai K; Onodera T; Miyata Y; Hamasaki T; Oshino S; Saitoh Y; Morii E; Otsuki M; Shimomura I
    Endocr J; 2016 Jun; 63(6):545-54. PubMed ID: 27025408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of NeuroD1 on the negative regulation of Pomc expression by glucocorticoid.
    Parvin R; Saito-Hakoda A; Shimada H; Shimizu K; Noro E; Iwasaki Y; Fujiwara K; Yokoyama A; Sugawara A
    PLoS One; 2017; 12(4):e0175435. PubMed ID: 28406939
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ubiquitin-Specific Protease 8 Mutant Corticotrope Adenomas Present Unique Secretory and Molecular Features and Shed Light on the Role of Ubiquitylation on ACTH Processing.
    Sesta A; Cassarino MF; Terreni M; Ambrogio AG; Libera L; Bardelli D; Lasio G; Losa M; Pecori Giraldi F
    Neuroendocrinology; 2020; 110(1-2):119-129. PubMed ID: 31280266
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A human ACTH-secreting corticotroph tumoroid model: Novel Human ACTH-Secreting Tumor Cell in vitro Model.
    Zhang D; Hugo W; Redublo P; Miao H; Bergsneider M; Wang MB; Kim W; Yong WH; Heaney AP
    EBioMedicine; 2021 Apr; 66():103294. PubMed ID: 33773184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Why don't corticotroph tumors always produce Cushing's disease?
    García-Martínez A; Cano DA; Flores-Martínez A; Gil J; Puig-Domingo M; Webb SM; Soto-Moreno A; Picó A
    Eur J Endocrinol; 2019 Sep; 181(3):351-361. PubMed ID: 31319379
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unrestrained production of proopiomelanocortin (POMC) and its peptide fragments by pituitary corticotroph adenomas in Cushing's disease.
    Bertagna X
    J Steroid Biochem Mol Biol; 1992 Oct; 43(5):379-84. PubMed ID: 1327071
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathophysiology and treatment of subclinical Cushing's disease and pituitary silent corticotroph adenomas [Review].
    Kageyama K; Oki Y; Nigawara T; Suda T; Daimon M
    Endocr J; 2014; 61(10):941-8. PubMed ID: 24974880
    [TBL] [Abstract][Full Text] [Related]  

  • 57. FAF1 Gene Involvement in Pituitary Corticotroph Tumors.
    Nguyen M; Maria AG; Faucz FR; Trivellin G; Stratakis CA; Tatsi C
    Horm Metab Res; 2024 Aug; 56(8):604-610. PubMed ID: 38065537
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Growth suppression of mouse pituitary corticotroph tumor AtT20 cells by curcumin: a model for treating Cushing's disease.
    Bangaru ML; Woodliff J; Raff H; Kansra S
    PLoS One; 2010 Apr; 5(4):e9893. PubMed ID: 20405005
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion.
    Auernhammer CJ; Chesnokova V; Bousquet C; Melmed S
    Mol Endocrinol; 1998 Jul; 12(7):954-61. PubMed ID: 9658400
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of proopiomelanocortin mRNA in the peripheral blood from patients with Cushing's syndrome of different origin.
    Bondioni S; Mantovani G; Polentarutti N; Ambrosi B; Loli P; Peverelli E; Lania AG; Beck-Peccoz P; Spada A
    J Endocrinol Invest; 2007 Nov; 30(10):828-32. PubMed ID: 18075284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.